Fulcrum Therapeutics Cut to Neutral From Overweight by Cantor Fitzgerald
Fulcrum Therapeutics Cut to Underperform From Neutral by B of A Securities
Interpublic Cut to Sell From Neutral by UBS
Micron Technology Cut to Underperform From Outperform by Exane BNP Paribas
Oncternal Therapeutics Cut to Hold From Buy by Brookline Capital
Oncternal Therapeutics Cut to Market Perform From Outperform by Northland Capital Markets
PotlatchDeltic Raised to Buy From Neutral by B of A Securities
Roku Raised to Outperform From Peer Perform by Wolfe Research
Simon Property Cut to Hold From Buy by Stifel
This article is a text version of a Wall Street Journal newsletter published earlier today.
(END) Dow Jones Newswires
September 13, 2024 06:12 ET (10:12 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。